Molecular detection of Chlaymydia trachomatis and HPV infections in cervical samples with normal and abnormal cytopathological findings

Diagnostic Cytopathology

Volumn 35, Issue 4, 2007, Pages 198-202

  De Paula, Francisco Danilo Ferreira ^a   Fernandes, Ana Paula ^a   Do Carmo, Bianca Bianco ^a   Vieira, Daniela Cristina Duarte ^a   Dutra, Miriam Santos ^a   Dos Santos, Caleb Guedes Miranda ^a   Souza, Maria Do Carmo M ^b   Andrade, Túlio César Alvim ^b   Vago, Annamaria Ravara ^a   Fernandes, Paula Ávila ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Distrito Centro Sul da Prefeitura de Belo Horizonte   (Brazil)

Author keywords

Cervical cancer; Chlamydia trachomatis; Human papillomaviruses (HPV); PCR; Squamous intraepithelial lesions

Indexed keywords

BACTERIAL DNA; VIRUS DNA;

ADULT; ARTICLE; BACTERIUM DETECTION; CHLAMYDIA TRACHOMATIS; CORRELATION ANALYSIS; DNA DETERMINATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS; CHLAMYDIASIS; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMA VIRUS; PATHOLOGY; PRECANCER; UTERINE CERVIX; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DNA, VIRAL; FEMALE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 34047141657     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.20629     Document Type: Article

References (46)

1. Ferenczy A, Franco E. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol 2002;3:11-16.
2. Brasil, Ministério da Saúde, Institute Nacional do Câncer 2006. Available at: http://www.inca.gov.br
3. Schiffman M, Castle PE. Human papillomavirus epidemiology and public health. Arch Pathol Lab Med 2003;127:930-934.
4. Franceschi S. The IARC commitment to cancer prevention: The example of papillomavirus and cervical cancer. Recent Results Cancer Res 2005;166:277-297.
5. Muñoz N. Human papillomavirus and cancer: The epidemiological evidence. J Clin Virol 2000;19:1-5.
6. Golijow CD, Abba MC, Mourón AS, Laguens RM, Dulout FN, Smith JS. Chlamydia trachomatis and Human papillomavirus infections in cervical disease in Argentine women. Gynecol Oncol 2005;96:181-186.
7. Lehmann M, Groh A, Rodel J, Nindl I, Straube E. Detection of Chlamydia trachomatis DNA in cervical samples with regard to infection by human papillomavirus. J Infect 1999;38:12-17.
8. Gopalkrishna V, Aggarwal N, Malhotra VL, et al. Chlamydia trachomatis and human papillomavirus infection in Indian women with sexually transmitted diseases and cervical precancerous and cancerous lesions. Clin Microbiol Infect 2000;6:88-93.
9. Finan RR, Tamim H, Almawi WY. Identification of Chlamydia trachomatis DNA in human papilomavirus (HPV) positive women with normal and abnormal cytology. Arch Gynecol Obstet 2002;266:168-171.
10. Tamim H, Finan RR, Sharida HE, Rashid M, Almawi WY. Cervico-vaginal co-infections with human papillomavirus and chlamydia trachomatis. Diag Microbiol Infect Dis 2002;43:277-281.
11. Smith JS, Muñoz N, Herrero R, et al. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Phillippines: J Infect Dis 2002;85:324-331.
12. Fischer N. Chlamydia trachomatis infection in cervical intraepithelial neoplasia and invasive carcinoma. Eur J Gynaec Oncol 2002;23:247-250.
13. Antilla T, Saikku P, Koskela P, et al. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA 2001;285:45-51.
14. Castle PE, Escoffery C, Schachter J, et al. Chlamydia trachomatis, herpes simplex virus 2, and human T-cell lymphotrophic virus type 1 are not associated with grade of cervical neoplasia in Jamaican colposcopy patients. Sex Transm Dis 2003;30:575-580.
15. Ferrera A, Baay MF, Herbrink P, Figueroa M, Velema JP, Melchers WJ. A sero-epidemiological study of the relationship between sexually transmitted agents and cervical cancer in Honduras. Int J Cancer 1997:73:781-785.
16. Takaé J, Gorisek B. The frequency of Chlamydia trachomatis infection in women with intraepithelial neoplasia of the uterine cervix. Eur J Gynaecol Oncol 1998:19:492-499.
17. Kurman RJ, Solomon D. The Bethesda System for reporting cervical/vaginal cytological diagnoses-Definitions, criteria and explanatory notes for terminology and specimen adequacy. New York: Springer; 1994. 81 p.
18. Villa LL, Caballero OL, Levi JE, Pena SDJ, Simpson AJG. An approach to human papillomavirus identification using low stringency single specific primer PCR. Mol Cell Probes 1995:9:45-48.
19. Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzimatic amplification of DNA with a thermostable DNA polymerase. Science 1988:239:487-491.
20. Manos MM, Ting Y, Wright DK, Lewis AI, Broker TR, Wolinsk SM. The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cell 1989:7:209-214.
21. Snijders PJ, Van Den Brule AJ, Schrijnemakers HF, Snow G, Meijer CJ, Walboomers JM. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Genet Virol 1990:71:173-181.
22. Cribb P, Scapini JP, Serra E. One-tube nested polymerase chain reaction for detection of Chlamydia trachomatis. Mem Inst Oswaldo Cruz 2002;97:897-900.
23. Sanguinetti CJ, Dias Neto E, Simpson AJG. Rapid silver staining and recovery of PCR products separated on polyacrylamide gels. Biotechniques 1994;17:915-918.
24. Nonnenmacher B, Breitenbach V, Villa LL, Prolla JC, Bozzetti MC. Genital human papillomavirus infection identification by molecular biology among asymptomatic women. Rev Saude Publica 2002;36:95-100.
25. De Lima Soares V, de Mesquita AM, Cavalcante FG, et al. Sexually transmitted infections in a female population in rural north-east Brazil: Prevalence, morbidity and risk factors. Trop Med Int Health 2003;8:595-603.
26. Muñoz L, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-527.
27. Amrani M, Lalaoui K, Mzibri ME, Lazo P, Belabbas MA. Molecular detection of human papillomavirus in 594 uterine cervix samples from Moroccan women (147 biopsies and 447 swabs). J Chin Virol 2003;27:286-295.
28. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997;102:3-8.
29. Cuschieri KS. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 2004;57:68-72.
30. Rosemblatt C, Lucon AM, Pereyra EAG, Pinotti JA, Arap S, Ruiz CA. HPV prevalence among partners of women with cervcal intraepithelial neoplasia. Int J Gynecol Obstet 2004;84:156-161.
31. Eluf-Neto J, Booth M, Muñoz N, Bosch FX, Meijer CJLM, Walboomers JM. Human papillomavirus and invasive cervical cancer in Brazil. Braz J Cancer 1994;69:114-119.
32. Bosch FX, Manos MM, Muñoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cancer cervical (IBSCC). J Natl Cancer Inst 1995;87:796-802.
33. Gonçalves MA, Massad E, Burattini MN, Villa LL. Relationship between human papillomavirus (HPV) genotyping and genital neoplasia in HIV-positive patients of Santos City, São Paulo, Brazil. Int J Std AIDS 1999;10:803-807.
34. Noronha V, Mello W, Villa LL, et al. Human papillomavirus associated with uterine cervix lesions. Rev Soc Bras Med Trop 1999:32:235-240.
35. Cavalcanti SMB, Zardol G, Passos MRL, Oliveira LHS. Epidemiological aspects of human papillomavirus infection and cervical cancer in Brazil. J Infect 2000;40:80-87.
36. Lorenzato F, Ho L, Terry G, et al. The use of human papillomavirus typing in detection of cervical neoplasia in Recife (Brazil). Int J Gynecol Cancer 2000;10:143-150.
37. Miranda AE, Gadelha AJ. Sexual and reproductive health among female adolescents: Preliminary results. Sex Transm Infect 2002;78:386-387.
38. Ramos MC, Becker D, Perin MT. Estudo populacional de prevalência de Chlamydia trachomatis e Neisseria gonorrhoeae pela reação em cadeia da polimerase em amostra de urina de mulheres residentes em vila popular da cidade de Porto Alegre, Brasil: Resultados preliminares. J Bras Doenças Sex Transm 2002;14:3.
39. Araújo RSC, Guimarães BEM. Estudo da infecção genital por Chlamydia trachomatis em adolescentes e jovens do sexo feminino no distrito sanitário Leste do Município de Goiânia: Prevalência e fatores de risco. Rev Bras Ginecol Obstet 2002;24:7.
40. Santos C, Teixeira F, Vicente A, Astolfi-Filho S. Detection of Chlamydia trachomatis in endocervical smears of sexually active women in Manaus-AM, Brazil, by PCR. Braz J Infect Dis 2003;7:91-95.
41. Molano M, Weiderpass E, Posso H, et al. Prevalence and determi-nants of Chlamydia trachomatis infections in women from Bogotá, Colômbia. Sex Transm Infect 2003;79:474-478.
42. Markowska J, Fischer N, Fischer Z, Warchol JB. Chlamydia trachomatis infection in women with CIN and invasive uterine cervix cancer. Significance of hormonal status. Eur J Gynaecol Oncol 2002;23:511-513.
43. Silins I, Ryd W, Strand A, et al. Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer 2005;116:110-115.
44. Silva CS, Adad SJ, Souza MAH, Barcelos ACM, Terra APS, Murta EFC. Increased frequency of bacterial vaginosis and Chlamydia trachomatis in pregnant women with human papillomavirus infection. Gynecol Obstet Invest 2004;58:189-193.
45. Cavaliere MJ, Maeda MY, Shirata NK, et al. Cervico-vaginal Chlamydia trachomatis infection in pregnant adolescent and adult women. A morphologic and immunofluorescent study. Arch Gynecol Obstet 1993;253:175-182.
46. Schlott T, Eiffert H, Bohne W, et al. Chlamydia trachomatis modulates expression of tumor suppressor gene caveolin-1 and oncogene C-myc in the transformation zone of non-neoplastic cervical tissue. Gynecol Oncol 2005;98:409-419.